159
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effect of Wuzhi capsules on cyclosporine A concentration in children with aplastic anemia immunotherapy: a single-center observational study

, ORCID Icon, , , &
Pages 365-369 | Received 28 Dec 2020, Accepted 25 Nov 2021, Published online: 04 Mar 2022

References

  • Peslak SA, Olson T, and Babushok DV. Diagnosis and treatment of aplastic anemia. Curr Treat Options Oncol. 2017;18(12):70.
  • Young NS. Aplastic Anemia. N Engl J Med. 2018;25(17):1643–1656.
  • Gaies E, Ben Sassi M, Charfi R, et al. Therapeutic Durg monitoring of cyclosporin using area under the curve in nephrotic syndrome. Tunis Med. 2019;97(2):360–364.
  • Amundsen R, Åsberg A, Ohm IK, et al. Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. Drug Metab Dispos. 40(4): 655–661. 2012;
  • Wang DD, Ye QF, Chen X, et al. Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients. Xenobiotica. 2020;50(4):435–441.
  • Li TF, Hu L, Ma XL, et al. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation. Acta Pharmacol Sin. 2019; 40(12): 1603–1610.
  • Helge D, Hartung MD, Timothy S. Acquired aplastic anemia in children. Pediatr Clin North Am. 2013;60(6):1311–1336.
  • Andreas HG, Robert T, Amit D, et al. Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transpl Infect Dis. 2017;19(5):1–11.
  • Fu R, Tajima S, Suetsugu K, et al. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacol Sin. 2019;40(2):151–159.
  • Wang C, Lu KP, Chang Z, et al. Association of CYP3A4*1B genotype with cyclosporin A pharmacokinetics in renal transplant recipients: a meta-analysis. Gene. 2018;664:44–49.
  • Choi JG, Eom SM, Kim J, et al. A comprehensive review of recent studies on herb-drug interaction: a focus on pharmacodynamic interaction. J Altern Complement Med. 2016;22(4):262–279.
  • Schultz KR, Nevill TJ, Balshaw RF, et al. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Bone Marrow Transplant. 2000;26(5):545–551.
  • Akool ES. Molecular mechanisms of the protective role of wheat germ oil against cyclosporin A-induced hepatotoxicity in rats. Pharm Biol. 2015;53(9):1311–1317.
  • Chen ZP, Liu F, Zheng NX. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. Biomed Pharmacother. 2019;110:285–293.
  • Xie Y, Hao H, Kang A, et al. Integral pharmacokinetics of multiple lignan components in normal, CCl 4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers. J Ethnopharmacol. 2010;131(2):290–299.
  • Loo WT, Cheung MN, Chow LW, et al. Fructus schisandrae (Wuweizi)-containing compound inhibits secretion of HBsAg and HBeAg in hepatocellular carcinoma cell line. Biomed Pharmacother. 2007;61(9):606–610.
  • Chen X, Wang DD, Xu H. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule. Xenobiotica. 2020;50(5):606–613.
  • Wang K, Qu QS, Zhang YX, et al. Effects of Wuzhi capsule on blood concentration of tacrolimus after renal transplantation. J Biol Regul Homeost Agents. 2016;30(1):155–159.
  • Chen X, Wang DD, Xu H, et al. Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics. Expert Rev Clin Pharmacol. 2020;13(5):553–561.
  • Xue XP, Qin XL, Xu CS, et al. Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats. Phytother Res. 2013;27(8):1255–1259.
  • Wim L, Bart M. In vivo assessment of cytochrome P450 3A4 and P-glycoprotein activity: impact on clinical practice. Curr Enzyme Inhib. 2007;3(3):217–241.
  • Jin J, Bi H, Hu J, et al. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats. Biopharm Drug Dispos. 2010;31(4):264–268.
  • Jin J, Bi H, Hu J, et al. Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of paclitaxel in rats. Phytother Res. 2011;25(8):1250–1253.
  • Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;31(2):139–152.
  • Xin HW, Wu XC, Li Q, et al. Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers. Br J Clin Pharmacol. 2009;67(5):541–546.
  • Parasrampuria DA, Mendell J, Shi M, et al. Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine. Br J Clin Pharmacol. 2016;82(6):1591–1600.
  • Fan JJ, Chen L, Lu XQ, et al. The pharmacokinetic prediction of cyclosporin A after coadministration with Wuzhi capsule. AAPS PharmSciTech. 20(6): 1–7. 2019;
  • Rezzani R. Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies. Histol Histopathol. 2006;21(3):301–316.
  • Zeng H, Li D, Qin X, et al. Hepatoprotective effects of Schisandra sphenanthera extract against lithocholic acid-induced cholestasis in male mice are associated with activation of the pregnane X receptor pathway and promotion of liver regeneration. Drug Metab Dispos. 2016;44(3):337–342.
  • Khadir F, Pouramir M, Joorsaraee SG, et al. The effect of arbutin on lipid peroxidation and antioxidant capacity in the serum of cyclosporine-treated rats. Caspian Journal of Internal Medicine. 2015;6(4):196–200.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.